Texas Pharmacy Act Amendment SB 1100 Effective 9/1/2013 Previously Reported but Summarized Here

S.B. 1100 Effective Date: 9/1/2013
This bill amends the Texas Pharmacy Act to:
give the Board the authority to inspect out-of-state sterile
compounding pharmacies;
 require out-of-state sterile compounding pharmacies to
reimburse the Board for travel expenses related to the
inspection;
 require an inspection prior to opening a sterile compounding
pharmacy; and
 specify that a pharmacy that compounds sterile preparations
may not renew a pharmacy license unless the pharmacy:
  has been inspected as provided by Board rule; and
 if the pharmacy is located in another state, has reimbursed
the Board for all expenses, including travel, incurred by the
Board in inspecting the pharmacy during the term of the
expiring license.
The bill also specifies that a pharmacy that compounds a sterile
preparation must notify the Board:
immediately of any adverse effects reported to the pharmacy
or that are known by the pharmacy to be potentially attributable
to a sterile preparation compounded by the pharmacy; and
 not later than 24 hours after the pharmacy issues a recall for a
sterile preparation compounded by the pharmacy